Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Trial ID or NCT#
NCT03391778
Status
RECRUITING
Purpose
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Official Title
Long-Term Follow-Up (LTFU) of Participants Treated With ADP Adoptive Cell Therapies
Eligibility Criteria
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * Participants who have received at least one dose of ADP adoptive cell therapy agent.* Participants who have completed ADP sponsored or supported interventional study or have withdrawn from it.* Participants who have completed treatment as part of managed access to a GSK adoptive cell therapy.* Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.* The investigator is responsible for review of medical history.* Capable of giving signed informed consent.
Exclusion Criteria:
- - None
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Ileana Aguilar Torres
650-724-1388
View on